Overview
Congenital systemic veins anomaly (also referred to as congenital anomalies of the systemic venous return) encompasses a group of rare developmental malformations affecting the major veins that return deoxygenated blood to the heart. These anomalies arise during embryonic development when the normal remodeling of the cardinal venous system fails to occur properly. The most commonly recognized forms include persistent left superior vena cava (PLSVC), absence or atresia of the right superior vena cava, anomalous drainage of the inferior vena cava (such as interrupted inferior vena cava with azygos or hemiazygos continuation), and duplication of the inferior vena cava. These conditions primarily affect the cardiovascular system. Many individuals with isolated systemic venous anomalies are asymptomatic, and the condition may be discovered incidentally during imaging studies or during placement of central venous catheters. However, in some cases, these anomalies can be associated with other congenital heart defects, including atrial septal defects, atrioventricular canal defects, or heterotaxy syndromes (abnormalities of left-right body asymmetry). When symptomatic, patients may experience arrhythmias, cyanosis (if there is right-to-left shunting), or complications related to associated cardiac malformations. In the context of heterotaxy, systemic venous anomalies may be part of a more complex clinical picture involving splenic abnormalities and visceral organ malposition. Treatment depends on the specific anomaly and its clinical significance. Isolated anomalies that are hemodynamically insignificant typically require no intervention but are important to document for future surgical or interventional planning. When associated with significant congenital heart disease, surgical correction may be necessary. Awareness of these anomalies is critical during cardiac surgery, pacemaker implantation, and central line placement to avoid complications. Long-term follow-up with a cardiologist is recommended for patients with complex forms or associated cardiac defects.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital systemic veins anomaly.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital systemic veins anomaly at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital systemic veins anomaly.
Community
No community posts yet. Be the first to share your experience with Congenital systemic veins anomaly.
Start the conversation →Latest news about Congenital systemic veins anomaly
No recent news articles for Congenital systemic veins anomaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital systemic veins anomaly
What is Congenital systemic veins anomaly?
Congenital systemic veins anomaly (also referred to as congenital anomalies of the systemic venous return) encompasses a group of rare developmental malformations affecting the major veins that return deoxygenated blood to the heart. These anomalies arise during embryonic development when the normal remodeling of the cardinal venous system fails to occur properly. The most commonly recognized forms include persistent left superior vena cava (PLSVC), absence or atresia of the right superior vena cava, anomalous drainage of the inferior vena cava (such as interrupted inferior vena cava with azyg
At what age does Congenital systemic veins anomaly typically begin?
Typical onset of Congenital systemic veins anomaly is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital systemic veins anomaly?
3 specialists and care centers treating Congenital systemic veins anomaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.